0 Commentarios
0 Acciones
47 Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
-
Please log in to like, share and comment!
-
AI-Powered Drug Delivery Systems Market to Surge as Precision Medicine Gains Momentum" According to the latest report published by Data Bridge Market Research, the AI-Powered Drug Delivery Systems Market CAGR Value Global AI-powered drug delivery systems market size was valued at USD 2.05 billion in 2024 and is projected to reach USD 10.15 billion by 2032, with a CAGR of 22.10% during the forecast period of 2025 to 2032 This AI-Powered Drug Delivery Systems...0 Commentarios 0 Acciones 5 Views 0 Vista previa
-
Could Precision Medicine Accelerate Innovation in the Peptide-Drug Conjugate Therapeutics Market?According to the latest report published by Data Bridge Market Research, the Peptide-Drug Conjugate Therapeutics Market CAGR Value The global peptide-drug conjugate therapeutics market size was valued at USD 1.46 billion in 2025 and is expected to reach USD 7.07 billion by 2033, at a CAGR of 21.80% during the forecast period Peptide-Drug Conjugate Therapeutics Market report...0 Commentarios 0 Acciones 35 Views 0 Vista previa
-
Hyper Personalized Medicine Market Advances Through Precision Oncology ApplicationsThe global Hyper Personalized Medicine Market is rapidly evolving as emerging technologies enable healthcare providers to deliver highly targeted therapies tailored to individual biological characteristics. According to Polaris Market Research, the market reached USD 2,256.42 billion in 2023 and is forecast to grow to USD 6,333.03 billion by 2032, expanding at a CAGR of 12.2%. The increasing...0 Commentarios 0 Acciones 29 Views 0 Vista previa
-
Multiomics Market Key Drivers Shaping Precision Medicine AdoptionThe healthcare and life sciences industries are experiencing a transformative shift driven by advances in multiomics technologies, integrated genomics and proteomics research, and sophisticated transcriptomics analysis platforms. These innovations are enabling scientists to gain a comprehensive understanding of biological systems by examining multiple layers of molecular information...0 Commentarios 0 Acciones 39 Views 0 Vista previa
-
Programmable RNA Therapeutics Market Gains Momentum with Advances in Precision Genetic Medicine" According to the latest report published by Data Bridge Market Research, the Programmable RNA Therapeutics Market CAGR Value The global Programmable RNA Therapeutics market size was valued at USD 1.16 billion in 2025 and is expected to reach USD 4.92 billion by 2033, at a CAGR of19.80% during the forecast period The Programmable RNA Therapeutics...0 Commentarios 0 Acciones 27 Views 0 Vista previa
-
Rare Disease Diagnostics Market Key Drivers Shaping Precision Medicine AdoptionRare diseases collectively affect millions of people worldwide, yet many patients experience lengthy diagnostic journeys before receiving an accurate diagnosis. Advances in genetic testing for rare diseases, comprehensive rare disease genetic testing, and innovative next generation sequencing diagnostics are revolutionizing how healthcare providers identify and manage these complex conditions....0 Commentarios 0 Acciones 60 Views 0 Vista previa
-
Blood-Based Biomarker for Alzheimer's Disease Diagnostics Market Regional Analysis and Future OutlookThe global Blood-Based Biomarker For Alzheimer’s Disease Diagnostics Market was valued at USD 169.2 million in 2025 and is projected to grow from USD 194.8 million in 2026 to USD 529.9 million by 2033, registering a CAGR of 17.4% from 2026 to 2033. North America dominated the global market with a 43.0% revenue share in 2025, driven by regulatory approvals, expanding clinical...0 Commentarios 0 Acciones 29 Views 0 Vista previa
-
Rare Disease Genetic Testing Market Competitive Analysis and Key PlayersThe global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...0 Commentarios 0 Acciones 32 Views 0 Vista previa
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek